Skip to content

Expiring federal contract

75N92026P00029 — Medunik USA INC

Department of Health and Human Services · National Institutes of Health

Contract / PIID
75N92026P00029
Incumbent
Medunik USA INC
Incumbent UEI
DND9H4EQ14T5
Current end date
December 31, 2026
Potential total value
$210,000
Obligated
$210,000
NAICS
325412 — Pharmaceutical Preparation Manufacturing
PSC
6505 — DRUGS AND BIOLOGICALS
Set-aside
Full & Open
Start date
December 19, 2025
Place of performance
NJ
Award type
PURCHASE ORDER

Source: USASpending.gov award record, last checked November 19, 2026. Place of performance as reported by USASpending.

What the contract covers

MEDICATION - PHENBURANE

Likely rebid window (estimate)

  • Sources Sought / RFI: about Dec 2025 – Jun 2026 (6–12 months before the end date)
  • RFP: about Aug 2026 – Oct 2026 (2–4 months before the end date)

In the final months before the current end date.

Estimated from the current end date using typical federal recompete timing. Agencies set their own schedules, and contracts are often extended. This is not a published solicitation date.

Track this recompete free

  • Change history: no changes recorded since Mindy began tracking this contract.
  • Alerts: get an email when the end date moves or the follow-on is posted.
  • Contacts: the buying office and small-business contacts for this agency.

Other contracts expiring at Department of Health and Human Services (NAICS 325412)